A looming revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster biotech stocks like Guardant Health, Natera and Exact Sciences.And all it takes is a little ...

After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase 3 trial and ...

The Summer Fridays Jet Lag Mask has been a viral cult hit since its launch. Now, meet the Jet Lag Eye Patches, a set of ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

The Food and Drug Administration on Thursday approved a core component of a brain implant made by Precision Neuroscience, a ...

Cathie Wood poured millions of dollars into Robinhood shares and a Toronto-listed Solana staking fund as the US Fed Chair's ...

With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.

Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down the company.

The rise of life science startups is revolutionizing healthcare, leveraging biotechnology to address critical health ...

The budget proposes a massive $20 billion cut for the NIH in 2026 — roughly a 40% reduction — and a sweeping consolidation, from 27 institutes and centers to just eight. Any final budget plan will ...

A Cambridge biotech has taken over development of a Roche rare disease drug, Cue Biopharma signed a deal with Boehringer ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.